Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

World HAI Forum lists priorities for fighting bacterial antibiotic resistance

08.07.2011
Over 70 international experts in medicine, infectious diseases, microbiology and epidemiology, coming from every continent, gathered at the Fondation Mérieux's Conference Center in Annecy (France) between 27 and 29 June 2011 for the third World HAI Forum on healthcare-associated infections, a biennial bioMérieux initiative.

The Forum's participants warned of an impending public-health catastrophe caused by the emergence and spread of bacteria that are resistant to all antibiotics, if no action is taken.

The delegates at the third World HAI Forum on healthcare-associated infections - a bioMérieux initiative taking place every two years - called upon national and international health authorities and policy makers, the medical and veterinary communities, industry, and the general public to take urgent action in order to avert potentially disastrous developments in public health, with the emergence and spread of multidrug-resistant bacteria.

While research to discover novel antibiotics has slowed to a virtual standstill, bacterial resistance has increased due to the massive use and misuse of antibiotics, not only for human health, but also for animals. The treatment of certain common infections is becoming difficult and the success of immunosuppressive therapies and surgical interventions (such as organ transplants and cardiac surgery), which are associated with a high risk of bacterial infection, could be compromised.

To the Forum's experts, the emergence of pan-resistant NDM-1 bacteria and the epidemic of multidrug-resistant E. coli infections, currently affecting Europe, should be taken as a major public-health warning, indicating that a new era of antimicrobial resistance has begun. This must lead to a global awakening: the protection of antibiotics has now entered the sphere of sustainable development.

In a continuation of calls to action and proposals made by major national and international organizations (WHO, ECDC, IDSA, CDC, etc.), the Forum's participants identified priority action areas to fight bacterial resistance and recommended 12 very concrete actions to be implemented, in the short to medium term, to effectively address this serious problem.

• Priority actions for policy makers and health authorities

-For animals, stop the administration of antibiotics used in human medicine and limit antibiotics to therapeutic use only. It is imperative to reserve the most important classes of antibiotics for humans.

-Banish, in all countries, the use of antibiotics as growth promoters in animal feed.

-Regulate the sale of antibiotics for use in human medicine and prohibit over-the-counter sales worldwide.

-Have international organizations (WHO, European Union) develop a charter on good antibiotic stewardship and have all the ministries of health worldwide sign it and commit to respecting it.

?Priority actions for the human and veterinary healthcare communities

-Establish standardized, universal surveillance of antibiotic use and resistance and monitor the emergence and spread of new forms of bacterial resistance.

-Include, in the medical- and veterinary-school curricula, a solid training in bacterial resistance and the prudent use of antibiotics and establish on-the-job training programmes for healthcare workers, taking into account the cultural specificities of each country.

• Priority actions for the general public

-Develop culturally sensitive awareness campaigns, targeted to the general public, explaining the importance of protecting antibiotics and using them only when absolutely necessary.

-Provide education about fundamental hygiene, such as hand-washing, to prevent the spread of infection. It is imperative to improve sanitation systems to eliminate resistant bacteria in wastewater.

-Include consumers in the development and implementation of action plans.

• Priority actions for industry

-Develop Point-of-Care and rapid diagnostic tests, which can be used at the patient's bedside or the doctor's office, to guide the prescription of antibiotics and avoid their prescription for viral infections.

-Stimulate research and development of novel antibiotics.

-Find new economic models, which reconcile public-health interests with industry needs for profitability.

About the World HAI Forum

The third biennial World HAI Forum took place in Annecy (in south-eastern France) from 27 to 29 June 2011. The Forum was characterized by the exceptional geographical diversity of its participants, coming from 33 countries.

While most such meetings focus on scientific developments retrospectively, in an academic format, the World HAI Forum, which is held every two years, gives participating experts a chance to do prospective analysis of subjects that are not usually discussed. More time is devoted to sharing best practices, successes and failures in the fight against multidrug-resistant bacteria, as a basis for building effective action plans.

A world leader in microbiology and a pioneer in resistance detection and susceptibility testing, bioMérieux works closely with healthcare professionals in the three key areas of infection control — prevention, surveillance and intervention. Diagnostic tests are paramount to success in the fight against infections with resistant bacteria.

As part of its commitment to fight hospital-acquired infections (HAIs) and microbial resistance, bioMérieux has also held HAI symposia around the world over the past three years, in countries including Belgium, China, Colombia, Japan, the Netherlands, Portugal, Saudi Arabia, South Korea, Spain and the United States.

To hear what experts discussed at the Forum, please go to: www.hai-forum.com

For further information about the Forum, please go to: www.bioMerieux.com/hai-resistance

About bioMérieux

• Advancing Diagnostics to Improve Public Health

A world leader in the field of in vitro diagnostics for over 45 years, bioMérieux is present in more than 150 countries through 39 subsidiaries and a large network of distributors. In 2010, revenues reached €1,357 billion, with 87% of sales outside France.

bioMérieux provides diagnostic solutions (reagents, instruments and software), which determine the source of disease and contamination to improve patient health and ensure consumer safety. The company's products are used for diagnosing infectious diseases and providing high-medical-value results for cancer screening and monitoring, and for cardiovascular emergencies. bioMérieux's solutions are also used for detecting micro-organisms in agri-food, pharmaceutical and cosmetic products.

bioMérieux is listed on the NYSE Euronext Paris stock exchange (Symbol: BIM — ISIN: FR0010096479).

For further information about bioMérieux, please go to: www.biomerieux.com

Mary-Ann Williams | UBIFRANCE
Further information:
http://www.ubifrance.com/uk/

More articles from Event News:

nachricht ICTM Conference 2017: Production technology for turbomachine manufacturing of the future
16.11.2016 | Fraunhofer-Institut für Produktionstechnologie IPT

nachricht Innovation Day Laser Technology – Laser Additive Manufacturing
01.11.2016 | Laser Zentrum Hannover e.V.

All articles from Event News >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>